COMMUNIQUÉS West-GlobeNewswire

ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON AND PARIS
09/11/2017
GHENT, Belgium, 9 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announces that it will participate in the following upcoming investor conferences taking place in London, UK and Paris, France: [...]
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
09/11/2017
CRESTWOOD, Ky., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease [...]
Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024
09/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
09/11/2017
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products [...]
New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
08/11/2017
SYDNEY, Australia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ: PBMD ) (“Prima”) is pleased to announce the presentation of new data from its TACTI-mel Phase I clinical trial in Australia [...]
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08/11/2017
ATLANTA, GA and BOTHELL, WA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing of its [...]
Atrion Corporation Declares Quarterly Cash Dividend
08/11/2017
ALLEN, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI ) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common [...]
ZoomMed Announces the Closing of a $500,000 Financing Agreement
08/11/2017
BROSSARD, Quebec, Nov. 08, 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX-V: ZMD ) announces the closing of a $500,000 secured financing agreement with a private investor dealing at arm’s length with ZoomMed. The loan bears [...]
ZoomMed annonce la clôture d’un financement de 500,000 $
08/11/2017
BROSSARD, Quebec, 08 nov. 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX CROISSANCE:ZMD) annonce la clôture d’un financement garanti au montant de 500 000 $ avec un investisseur privé traitant à distance avec ZoomMed. Le [...]
Spine Injury Solutions Schedules Interactive Conference Call to Present 3rd Quarter 2017 Financial Results, Provide Business Development Update
08/11/2017
HOUSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, and healthcare solution company servicing the multi-billion dollar spine injury sector, through [...]
Genmab Announces Financial Results for the First Nine Months of 2017
08/11/2017
November 8, 2017; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2017 Highlights USD 871 million in net sales of DARZALEX ® (daratumumab); resulting in royalty income of DKK 707 [...]
Des héros du DT1 de FRDJ militent pour la couverture des pompes à insuline au Manitoba
08/11/2017
WINNIPEG, Manitoba, 08 nov. 2017 (GLOBE NEWSWIRE) -- La journée de défense d’intérêts 2017 au Manitoba est l’occasion de faire avancer la cause. Aujourd’hui, 10 héros du DT1 – des défenseurs qui vivent avec le diabète [...]
JDRF’s T1D Heroes Advocating for Insulin Pump Coverage in Manitoba
08/11/2017
WINNIPEG, Manitoba, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Manitoba Lobby Day 2017 is an opportunity to make a difference. Today, 10 T1D Heroes – advocates living with type 1 diabetes (T1D) – are at the Manitoba Legislative [...]
CV Sciences, Inc. Reports Third Quarter 2017 Financial Results
08/11/2017
- Record Quarter for all Financial Performance Metrics - Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results LAS VEGAS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ( [...]
TPP Healthcare Launches New Website to Provide Stronger Insight to the World of Cross-Border Trade
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- TPP Healthcare , a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www. [...]
RedHill Biopharma Prices Public Offering of its American Depositary Shares
08/11/2017
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 08, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results
08/11/2017
VANCOUVER, British Columbia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in [...]
Zealand Pharma: Interim report for the first nine months of 2017
08/11/2017
Company announcement - No. 50/2017 Interim report for the first nine months of 2017 Copenhagen, November 8, 2017 - Zealand Pharma A/S ("ZEAL") announces financial results and continued strong progress for its product [...]
Travelan Experiences Strong Q1 FY2018 Sales Growth
08/11/2017
Key Highlights: Significant growth of sales for Immuron’s over-the-counter supplement Travelan ® for Q1 2018 compared to Q1 2017 Travelan ® US experienced a 197% increase in sales compared to Q1 2017 Travelan ® [...]

Pages